Example: stock market
医薬品インタビューフォーム - bij-kusuri.jp
2015 年7 月作成（第1 版） 日本標準商品分類番号. 87399 . 医薬品インタビューフォーム 日本病院薬剤師会のif 記載要領2013 に準拠して作成
Information
Domain:
Source:
Link to this page:
Related documents
SCHEDA FARMACO - osservatorioinnovazione.net
www.osservatorioinnovazione.netESTAV Centro •Sede legale 50125 Firenze Viale Michelangiolo 41 • Telefono 055 6577 328-453 • Fax 055 6577547 P.I. e C.F. 05577300485 • www. estav-centro.toscana.it • direzione@estav-centro.toscana.it SCHEDA FARMACO (a cura di UOS Farmacoeconomia e HTA, Area Centro) Principio attivo (nome commerciale) Nintedanib …
Development and validation of a simple and …
www.jocpr.comDevelopment and validation of a simple and sensitive ... ... Nintedanib
D r u g N e w s - drugoffice.gov.hk
www.drugoffice.gov.hkDrug Office, Page 3 Department of Health, Hong Kong SAR Safety Update infections, including fatal fungal infections, than clinical trial data predicted.
WHO Drug Information
www.who.intPre-publication draft - page numbers are not for citation purposes 1 WHO Drug Information Vol. 30, No. 1, 2016 Contents Concept paper for comment
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.com3 3 DOSAGE FORMS AND STRENGTHS 150 mg capsules: brown, opaque, oblong, soft capsules imprinted in black with the Boehringer Ingelheim company symbol and "150".